Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors
Tóm tắt
Từ khóa
Tài liệu tham khảo
Webb, 1963, Vol. 1, 55
Dixon, 1979, Enzymes, 332
Cleland, 1963, The kinetics of enzyme catalyzed reactions with two or more substrates or products, Biochim. Biophys. Acta, 67, 173, 10.1016/0926-6569(63)90226-8
Segel, 1975, Multiple inhibition analysis, 465
Chou, 1974, Relationships between inhibition constants and fractional inhibition in enzyme-catalyzed reactions with different numbers of reactants, different reaction mechanisms, and different types and mechanisms of inhibition, Mol. Pharmacol., 10, 235
Chou, 1976, Derivation and properties of Michaelis-Menten type and Hill type equations for reference ligands, J. Theor. Biol., 59, 253, 10.1016/0022-5193(76)90169-7
Chou, 1977, On the determination of availability of ligand binding sites in steady-state systems, J. Theor. Biol., 65, 345, 10.1016/0022-5193(77)90329-0
Chou, 1977, A simple generalized equation for the analysis of multiple inhibitions of Michaelis-Menten kinetic systems, J. Biol. Chem., 252, 6438, 10.1016/S0021-9258(17)39978-7
Finney, 1952, Probit Analysis, 146
Bliss, 1967
Reed, 1929, The application of the logistic function to experimental data, J. Physical Chem., 33, 760, 10.1021/j150299a014
Nordling, 1953, A new theory of the cancer-inducing mechanism, Brit. J. Cancer, 7, 68, 10.1038/bjc.1953.8
Chou, 1983, Analysis of combined drug effects: A new look at a very old problem, Trends in Pharmacol. Sci., 4, 450, 10.1016/0165-6147(83)90490-X
Michaelis, 1913, Die Kinetik der Invertinwirkung, Biochem. Z., 49, 333
Hill, 1913, The combinations of hemoglobin with oxygen and with carbon monoxide, Biochem. J., 7, 471, 10.1042/bj0070471
Langmuir, 1918, The adsorption of gases on plane surfaces of glass, mica and platinum, J. Am. Chem. Soc., 40, 1361, 10.1021/ja02242a004
Clark, 1928
Catchard, 1949, The attractions of proteins for small molecules and ions, Ann., N.Y. Acad. Sci., 51, 660, 10.1111/j.1749-6632.1949.tb27297.x
Tallarida, 1979
Chou, 1975, Metabolism and selective effects of 1-β-d-arabinofuranosylcytosine in L1210 and host tissues in vivo, Cancer Res, 35, 225
Kremer, 1980, The active site of transketolase: Two arginine residues are essential for activity, J. Biol. Chem., 255, 2405, 10.1016/S0021-9258(19)85906-9
Bounias, 1980, Correlations between glucose-inhibition and control parameters of α-glucosidase kinetics in Apis mellifica haemolymph, Experienta, 36, 157, 10.1007/BF01953704
Finotti, 1981, Canrenome as a partial agonist at the digitalis receptor site of sodium-potassium-activated adenosine triphosphatase, J. Pharmacol. Exptl. Therap., 217, 784
Hata, 1981, Purification and properties of γ-glutamyl transpeptidase from bovine parotid gland, Int. J. Biochem., 13, 681, 10.1016/0020-711X(81)90036-7
Bounias, 1982, Kinetic study of the inhibition of the honeybee haemolymph α-glucosidase in vitro by BAYe 4609, BAYg 5421 and BAYn 5595, Biochem. Pharmacol., 31, 2769, 10.1016/0006-2952(82)90131-9
Steckel, 1983, Kinetic properties and inhibition of Acinetobacter glutaminase-asparaginase, Biochem. Pharmacol., 32, 971, 10.1016/0006-2952(83)90613-5
Friedman, 1980, Membrane-active drugs potentiate the killing of tumor cells by d-glucosamine, 77, 1172
Rosenberg, 1981, A kinetic analysis of l-tryptophan transport in human red blood cells, Biochim. Biophys. Acta, 649, 262, 10.1016/0005-2736(81)90414-4
Chou, 1975, A general procedure for determination of median-effect doses by a double logarithmic transformation of dose-response relationships, 34, 228
Chou, 1980, Comparison of dose-effect relationships of carcinogens following low-dose chronic exposure and high-dose single injection: An analysis by the median-effect principle, Carcinogenesis, 1, 203, 10.1093/carcin/1.3.203
Chou, 1981, Carcinogenic risk assessment by a mass-action law principle: Application to large scale chronic feeding experiment with 2-acetylaminofluorene (2-AAF), 22, 141
Teller, 1982, Therapy of DMBA-induced rat mammary carcinomas with combinations of 5-fluorouracil and 2α-methyldihydrotestosterone propionate, Cancer Res., 42, 4408
Murphy, 1982, Heterogeneity of adenosine A1 receptor binding in brain tissue, Mol. Pharmacol., 22, 250
Vauquelin, 1982, Agonist-mediated conformational changes of muscarinic receptors in rat brain, Europ. J. Biochem., 125, 117, 10.1111/j.1432-1033.1982.tb06658.x
Viswanathan, 1981, Effects of 1-arylpyrroles and naphthoflavones upon cytochrome P-450 dependent monooxygenase activities, J. Med. Chem., 24, 822, 10.1021/jm00139a011
Smith, 1982, A model of labelled-ligand displacement assay resulting in logit-log relationships, J. Theor. Biol., 98, 475, 10.1016/0022-5193(82)90132-1
Chou, 1983, Computer simulation of drug effects: Quantitation of synergism, summation and antagonism of multiple drugs, Pharmacologist, 25, 175
Goldin, 1957, The employment of combinations of drugs in the chemotherapy of neoplasia: A review, Cancer Res., 17, 635
Berenbaum, 1977, Synergy, additivism and antagonism in immunosuppression: A critical review, Clin. Exptl. Immunol., 28, 1
Loewe, 1928, Die quantitation probleme der pharmakologie, Ergebn. Physiol., 27, 47, 10.1007/BF02322290
Loewe, 1953, The problem of synergism and antagonism of combined drugs, Arzeimittelforsch., 3, 285
Webb, 1963, Effect of more than one inhibitor, Vol. 1, 66
Webb, 1963, Effect of more than one inhibitor, Vol. 1, 488
Veldstra, 1956, Synergism and potentiation with special reference to the combination of structural analogues, Pharmacol. Rev., 8, 339
Lacey, 1958, Mechanisms of chemotherapeutic synergy, 247
Goodman, 1964, The problem of drug efficacy: An exercise in dissection, 49
Venditti, 1964, Drug synergism in anti-neoplastic chemotherapy, Vol. 1, 397
Sartorelli, 1965, Approaches to the combination chemotherapy of transplantable neoplasms, Vol. 6, 229
Goldin, 1968, Evaluation of combination chemotherapy with three drugs, Cancer Res., 28, 950
Skipper, 1974, Combination therapy: Some concepts and results, Cancer Chemother. Rep., 5, 137
Schabel, 1975, Synergism and antagonism among antitumor agents, 595
Grindey, 1975, Approaches to the rational combination of antimetabolites for cancer chemotherapy, Vol. 5, 169
Johnson, 1945, The nature and control of reactions in bioluminescence, J. Gen. Physiol., 28, 463, 10.1085/jgp.28.5.463
Yagi, 1960, Complex formation of apo-enzyme, coenzyme and substrate of d-amino acid oxidase, Biochim. Biophys. Acta, 42, 381, 10.1016/0006-3002(60)90815-5
Ariens, 1961, Analysis of the action of drugs and drug combinations, 286
Ariens, 1961, Analysis of the action of drugs and drug combinations, 318
Yonetani, 1964, Studies on liver alcohol dehydrogenase complexes, 106, 243
Keleti, 1971, The system of double inhibitions, Math. Biosci., 12, 197, 10.1016/0025-5564(71)90016-2
Fajszi, 1974, Methods of analysis of double inhibitor experiments, 18, 77
Northrop, 1974, The kinetics of pig heart triphosphopyridine nucleotide-isocitrate dehydrogenase, J. Biol. Chem., 249, 2928, 10.1016/S0021-9258(19)42720-8
Chou, 1981, Generalized equations for the analysis of inhibitions of Michaelis-Menten and higher-order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors, Europ. J. Biochem., 115, 207, 10.1111/j.1432-1033.1981.tb06218.x